Reviva Pharmaceuticals Holdings, Inc.
corporate_fare Company Profile
Reviva Pharmaceuticals Holdings, Inc. (OTC:RVPH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for RVPH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-12, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for RVPH spans 10-Q, 8-K, 10-K, SCHEDULE 13D/A.
Recent high-impact activity:
- Reviva's Q2 2026: Cash Runway to July 2027, but Going Concern Lingers
- Reviva Posts Narrower Q2 Loss, $19.9M Cash, and New Patent Strategy to Extend Brilaroxazine Exclusivity to 2046
- Nasdaq Delisting Confirmed, Going Concern Warning Persists Amidst Highly Dilutive Capital Raises
- Q1 Results Show Reduced Loss, Increased Cash Amid Nasdaq Delisting
- Reviva Pharmaceuticals to be Delisted from Nasdaq, Moving to OTCQB
Financial Snapshot
Short Interest & Short Volume
7.52 days to coverFINRA reported short interest of 405,082 shares in RVPH as of the September 15, 2026 settlement, a 1.2% increase from the prior period — about 7.5 days to cover at its recent average daily volume. On October 2, 2026, 4.5% of RVPH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.